BRAIDWELL LP
Filing Date
Global Rank
#1,146
/ 8,700
▲ 150
Top Industry
Biotechnology
58.8%
Period ended 2 months ago
Filed Aug 14, 2026 · 30d
15 quarters · since Dec 2022
Portfolio Concentration
83 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
5.6%
−0.2 pts
Top 5
19.2%
+0.2 pts
Top 10
32.5%
−0.6 pts
HHI
202
Diversified−5
Portfolio Trend
15 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 99.1% | $2,580,189,715 |
| Financial Services | 0.9% | $23,808,000 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
20 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ATEC | Alphatec Holdings, Inc. | +4,358,714 | 6,531,439 | $56,496,947 | |
| CLYM | Climb Bio, Inc. | +1,267,700 | 2,797,375 | $36,477,770 | |
| AVAH | Aveanna Healthcare Holdings, Inc. | +861,600 | 3,065,106 | $26,267,958 | |
| DMRA | Damora Therapeutics, Inc. | +725,531 | 1,620,377 | $42,146,005 | |
| ACHC | Acadia Healthcare Company, Inc. | +495,577 | 1,141,477 | $33,707,815 | |
| ACRS | Aclaris Therapeutics, Inc. | +443,232 | 2,142,348 | $11,333,020 | |
| CRVS | Corvus Pharmaceuticals, Inc. | +373,500 | 2,126,298 | $31,766,892 | |
| TMDX | TransMedics Group, Inc. | +280,324 | 609,715 | $40,497,270 | |
| NKTR | Nektar Therapeutics | +250,916 | 473,617 | $33,063,202 | |
| CAI | Caris Life Sciences, Inc. | +246,585 | 8,256,032 | $147,122,490 | |
| BSX | Boston Scientific Corp | +241,100 | 587,567 | $25,077,359 | |
| RGEN | Repligen Corp | +129,600 | 177,100 | $24,163,524 | |
| VOR | Vor Biopharma Inc. | +106,330 | 573,104 | $10,550,844 | |
| ORIC | Oric Pharmaceuticals, Inc. | +86,500 | 1,214,540 | $13,153,468 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | +70,500 | 381,128 | $42,316,641 | |
| EOLS | Evolus, Inc. | +50,000 | 3,155,209 | $21,897,150 | |
| IRTC | iRhythm Holdings, Inc. | +44,070 | 654,262 | $77,824,464 | |
| VERA | Vera Therapeutics, Inc. | +40,900 | 564,724 | $24,232,306 | |
| KYMR | Kymera Therapeutics, Inc. | +40,604 | 378,163 | $43,363,951 | |
| DHR | Danaher Corp /De/ | +11,300 | 150,627 | $28,691,430 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| MRVI | Maravai Lifesciences Holdings, Inc. | −1,537,243 | 8,702,921 | $54,306,227 | |
| CDNA | CareDx, Inc. | −952,544 | 1,220,602 | $34,787,157 | |
| CLDX | Celldex Therapeutics, Inc. | −919,436 | 436,646 | $16,247,597 | |
| ACAD | Acadia Pharmaceuticals Inc | −824,800 | 1,646,399 | $41,653,894 | |
| MBX | MBX Biosciences, Inc. | −781,587 | 710,880 | $39,240,576 | |
| DYN | Dyne Therapeutics, Inc. | −760,400 | 921,598 | $20,468,691 | |
| GLUE | Monte Rosa Therapeutics, Inc. | −755,012 | 2,451,562 | $59,327,800 | |
| NEO | Neogenomics Inc | −699,200 | 4,918,202 | $71,756,567 | |
| NRIX | Nurix Therapeutics, Inc. | −463,997 | 1,286,769 | $31,217,015 | |
| BTSG | BrightSpring Health Services, Inc. | −419,809 | 596,753 | $41,617,554 | |
| GH | Guardant Health, Inc. | −351,862 | 147,850 | $22,181,935 | |
| EWTX | Edgewise Therapeutics, Inc. | −350,618 | 1,996,965 | $81,136,687 | |
| XFOR | X4 Pharmaceuticals, Inc | −350,200 | 2,922,754 | $13,649,261 | |
| NBIX | Neurocrine Biosciences Inc | −315,950 | 336,171 | $56,658,260 | |
| GENB | Generate Biomedicines, Inc. | −309,155 | 3,283,844 | $55,398,448 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | −304,802 | 594,562 | $57,957,903 | |
| TECX | Tectonic Therapeutic, Inc. | −250,251 | 596,900 | $20,521,422 | |
| XENE | Xenon Pharmaceuticals Inc. | −207,000 | 1,131,452 | $68,294,442 | |
| GKOS | GLAUKOS Corp | −171,578 | 591,927 | $82,727,717 | |
| BIOA | BioAge Labs, Inc. | −167,458 | 1,033,129 | $25,321,991 | |
| HNGE | Hinge Health, Inc. | −124,996 | 1,330,127 | $110,400,541 | |
| KNSA | Kiniksa Pharmaceuticals International, plc | −88,700 | 183,822 | $11,755,416 | |
| ARGX | Argenx SE | −67,232 | 17,707 | $16,428,023 | |
| DRUG | Bright Minds Biosciences Inc. | −55,886 | 483,822 | $33,964,304 | |
| KRYS | Krystal Biotech, Inc. | −53,450 | 128,975 | $47,936,138 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
24 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| HUM | Humana Inc | 114,500 | $45,481,690 | |
| MAZE | Maze Therapeutics, Inc. | 1,140,040 | $34,018,793 | |
| AVTX | Avalo Therapeutics, Inc. | 1,629,182 | $30,107,283 | |
| ALMR | Alamar Biosciences, Inc. | 1,083,983 | $29,365,099 | |
| ORKA | Oruka Therapeutics, Inc. | 278,164 | $26,472,867 | |
| AVLN | Avalyn Pharma Inc. | 801,395 | $26,381,923 | |
| IMCR | Immunocore Holdings plc | 521,327 | $16,552,132 | |
| OVID | Ovid Therapeutics Inc. | 5,919,464 | $15,923,358 | |
| MNKD | Mannkind Corp | 3,458,429 | $14,732,907 | |
| QURE | uniQure N.V. | 301,652 | $13,894,091 | |
| OCS | Oculis Holding AG | 834,183 | $11,570,118 | |
| SPTX | Seaport Therapeutics, Inc. | 500,000 | $10,860,000 | |
| IMUX | Immunic, Inc. | 645,010 | $9,913,803 | |
| DGX | Quest Diagnostics Inc | 43,200 | $9,156,240 | |
| ANL | Adlai Nortye Group Ltd. | 795,214 | $9,144,961 | |
| TENX | Tenax Therapeutics, Inc. | 584,412 | $8,503,194 | |
| KARD | Kardigan, Inc. | 300,000 | $7,155,000 | |
| AMAN | Amanat Acquisition Corp. | 700,000 | $7,112,000 | |
| COAG | Hemab Therapeutics Holdings, Inc. | 160,000 | $5,876,800 | |
| GHRS | GH Research PLC | 207,240 | $5,570,611 | |
| WAT | Waters Corp /De/ | 14,040 | $5,265,561 | |
| RACC | Research Alliance Corp III | 400,000 | $4,280,000 | |
| JATT | JATT II Acquisition Corp. | 250,000 | $2,840,000 | |
| CYCN | Korsana Biosciences, Inc. | 156,890 | $531,857 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
23 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| CGON | CG Oncology, Inc. | 984,783 | $66,650,113 | |
| APGE | Apogee Therapeutics, Inc. | 478,667 | $40,289,401 | |
| PEN | Penumbra Inc | 105,352 | $34,594,436 | |
| ILMN | Illumina, Inc. | 229,215 | $28,253,040 | |
| BMRN | Biomarin Pharmaceutical Inc | 497,020 | $28,076,659 | |
| ESTA | Establishment Labs Holdings Inc. | 463,600 | $26,323,208 | |
| FULC | Fulcrum Therapeutics, Inc. | 3,134,922 | $24,044,851 | |
| CVS | CVS HEALTH Corp | 290,700 | $20,878,074 | |
| TARS | Tarsus Pharmaceuticals, Inc. | 265,715 | $18,639,907 | |
| ENGN | enGene Therapeutics Inc. | 2,456,870 | $16,731,284 | |
| TGTX | Tg Therapeutics, Inc. | 358,800 | $11,919,336 | |
| CNC | Centene Corp | 330,000 | $10,804,200 | |
| CMPX | Compass Therapeutics, Inc. | 1,965,106 | $10,395,410 | |
| RVMD | Revolution Medicines, Inc. | 84,900 | $8,256,525 | |
| GRAL | GRAIL, Inc. | 142,755 | $7,377,578 | |
| DNLI | Denali Therapeutics Inc. | 296,324 | $5,689,420 | |
| HROW | Harrow, Inc. | 156,419 | $5,515,333 | |
| RVTY | Revvity, Inc. | 48,400 | $4,240,324 | |
| CELC | Celcuity Inc. | 29,198 | $3,332,659 | |
| PRAX | Praxis Precision Medicines, Inc. | 9,976 | $3,214,167 | |
| — | 959,259 | $0 | ||
| CNTA | Centessa Pharmaceuticals plc | 1,986,768 | $0 | |
| — | 700,429 | $0 | ||
| No positions match the current search. | ||||
83 tracked positions ·
$2,603,997,715 total
· filing declares
86 positions · $2,703,471,368
· as of Jun 30, 2026
Showing 1–50
of 83 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| CAI |
Caris Life Sciences, Inc.
Healthcare
|
Added | 8,256,032 | $147,122,490 | 5.65% | |
| HNGE |
Hinge Health, Inc.
Healthcare
|
Reduced | 1,330,127 | $110,400,541 | 4.24% | |
| GKOS |
GLAUKOS Corp
Healthcare
|
Reduced | 591,927 | $82,727,717 | 3.18% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Reduced | 1,996,965 | $81,136,687 | 3.12% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Reduced | 879,467 | $78,079,080 | 3.00% | |
| IRTC |
iRhythm Holdings, Inc.
Healthcare
|
Added | 654,262 | $77,824,464 | 2.99% | |
| NEO |
Neogenomics Inc
Healthcare
|
Reduced | 4,918,202 | $71,756,567 | 2.76% | |
| KOD |
Kodiak Sciences Inc.
Healthcare
|
Reduced | 1,787,318 | $69,633,909 | 2.67% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Reduced | 1,131,452 | $68,294,442 | 2.62% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
Reduced | 2,451,562 | $59,327,800 | 2.28% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Reduced | 594,562 | $57,957,903 | 2.23% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Reduced | 336,171 | $56,658,260 | 2.18% | |
| ATEC |
Alphatec Holdings, Inc.
Healthcare
|
Added | 6,531,439 | $56,496,947 | 2.17% | |
| GENB |
Generate Biomedicines, Inc.
Healthcare
|
Reduced | 3,283,844 | $55,398,448 | 2.13% | |
| MRVI |
Maravai Lifesciences Holdings, Inc.
Healthcare
|
Reduced | 8,702,921 | $54,306,227 | 2.09% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
Reduced | 128,975 | $47,936,138 | 1.84% | |
| HUM |
Humana Inc
Healthcare
|
NEW | 114,500 | $45,481,690 | 1.75% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
Reduced | 89,395 | $44,819,077 | 1.72% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
Added | 378,163 | $43,363,951 | 1.67% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Added | 381,128 | $42,316,641 | 1.63% | |
| DMRA |
Damora Therapeutics, Inc.
Healthcare
|
Added | 1,620,377 | $42,146,005 | 1.62% | |
| ACAD |
Acadia Pharmaceuticals Inc
Healthcare
|
Reduced | 1,646,399 | $41,653,894 | 1.60% | |
| BTSG |
BrightSpring Health Services, Inc.
Healthcare
|
Reduced | 596,753 | $41,617,554 | 1.60% | |
| TMDX |
TransMedics Group, Inc.
Healthcare
|
Added | 609,715 | $40,497,270 | 1.56% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Reduced | 710,880 | $39,240,576 | 1.51% | |
| CLYM |
Climb Bio, Inc.
Healthcare
|
Added | 2,797,375 | $36,477,770 | 1.40% | |
| CDNA |
CareDx, Inc.
Healthcare
|
Reduced | 1,220,602 | $34,787,157 | 1.34% | |
| MAZE |
Maze Therapeutics, Inc.
Healthcare
|
NEW | 1,140,040 | $34,018,793 | 1.31% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
Reduced | 483,822 | $33,964,304 | 1.30% | |
| ACHC |
Acadia Healthcare Company, Inc.
Healthcare
|
Added | 1,141,477 | $33,707,815 | 1.29% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
Added | 473,617 | $33,063,202 | 1.27% | |
| CRVS |
Corvus Pharmaceuticals, Inc.
Healthcare
|
Added | 2,126,298 | $31,766,892 | 1.22% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Reduced | 1,286,769 | $31,217,015 | 1.20% | |
| INSP |
Inspire Medical Systems, Inc.
Healthcare
|
Held | 677,570 | $30,226,397 | 1.16% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
NEW | 1,629,182 | $30,107,283 | 1.16% | |
| ALMR |
Alamar Biosciences, Inc.
Healthcare
|
NEW | 1,083,983 | $29,365,099 | 1.13% | |
| DHR |
Danaher Corp /De/
Healthcare
|
Added | 150,627 | $28,691,430 | 1.10% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Reduced | 70,137 | $27,892,082 | 1.07% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
NEW | 278,164 | $26,472,867 | 1.02% | |
| AVLN |
Avalyn Pharma Inc.
Healthcare
|
NEW | 801,395 | $26,381,923 | 1.01% | |
| AVAH |
Aveanna Healthcare Holdings, Inc.
Healthcare
|
Added | 3,065,106 | $26,267,958 | 1.01% | |
| BIOA |
BioAge Labs, Inc.
Healthcare
|
Reduced | 1,033,129 | $25,321,991 | 0.97% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Added | 587,567 | $25,077,359 | 0.96% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Added | 564,724 | $24,232,306 | 0.93% | |
| RGEN |
Repligen Corp
Healthcare
|
Added | 177,100 | $24,163,524 | 0.93% | |
| ZURA |
Zura Bio Ltd
Healthcare
|
Reduced | 3,980,295 | $23,483,740 | 0.90% | |
| GH |
Guardant Health, Inc.
Healthcare
|
Reduced | 147,850 | $22,181,935 | 0.85% | |
| EOLS |
Evolus, Inc.
Healthcare
|
Added | 3,155,209 | $21,897,150 | 0.84% | |
| NTRA |
Natera, Inc.
Healthcare
|
Reduced | 79,500 | $21,580,275 | 0.83% | |
| KIDS |
Orthopediatrics Corp
Healthcare
|
Held | 1,100,370 | $21,050,078 | 0.81% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.